A first-in-human, proof-of-concept phase I study of PIN-2 in oncology patients with solid tumors.
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2017
At a glance
- Drugs PIN 2 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man; Proof of concept
- 22 Nov 2017 New trial record
- 15 Nov 2017 According to a PIN Pharma Inc media release, the company today announced the initiation of this study and anticipate having interim data by the upcoming JP Morgan conference this January 2018.